Technologies Bv Marr serves as Executive at CALYPTE BIOMEDICAL CORP, where they oversee executive responsibilities. Since joining the company, Technologies Bv Marr has executed 2 insider transactions totaling $2.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 21, 2006 involved purchasing 16,964,583 shares valued at $2.5M.
Technologies Bv Marr currently holds 16,964,583 shares of CALYPTE BIOMEDICAL CORP (CBMC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Technologies Bv Marr has been a net buyer of CBMC stock. They have purchased $2.5M and sold $0 worth of shares.
Technologies Bv Marr's most recent insider trade was on Jul 21, 2006, when they purchased 16,964,583 shares at $0.15 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |